This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Xeljanz®(tofacitinib citrate)Prescribing information, Enbrel®(etanercept) Prescribing information, Inflectra®(infliximab) Prescribing information and Maxtrex(methotrexate) Prescribing information. Adverse event reporting can be found at the bottom of the page.
Rheumatoid Arthritis impacts patients in their everyday lives. A number of studies have addressed this issue through patient self-reported questionnaires and interviews.25a 26a Some of the key findings of how RA impacts patients in their work-life, daily activities, emotions, and relationships are detailed below.
Patients with RA have reported being less productive due to RA.25b 27a In some cases, this included leaving the workforce due to RA, the primary reasons being fatigue, pain or stiffness, and mobility difficulties.26b Lost productivity contributes to the economic burden of RA.28
Patients have reported difficulty performing valued life activities, including gardening, minor repairs, hobbies, activities with children, and physically strenuous leisure activities.29a
Patients with RA often have depression or depressive symptoms.27b Depression has been associated with increases in mortality, cardiovascular problems, and disability in patients with RA.27c
In a study of women with RA, patients reported concealing their pain from others and feeling that others do not understand their pain or fatigue.25c
Click below to view the Immuno-navigator tool. An interactive tool to help you manage discussions with your patients .
25 - Strand V, Wright GC, Bergman MJ, Tambiah J, Taylor PC. Patient expectations and perceptions of goal-setting strategies for disease management in rheumatoid arthritis. J Rheumatol. 2015; 42(11):2046-2054.
26 - Bertin P, Fagnani F, Duburcq A, et al. Impact of rheumatoid arthritis on career progression, productivity, and employability: the PRET Study. Joint Bone Spine. 2016; 83(1):47-52.
27 - Cutolo M, Kitas GD, van Riel PLCM. Burden of disease in treated rheumatoid arthritis patients: going beyond the joint. Semin Arthritis Rheum. 2014; 43:479-488.
28 - Zhu TY, Tam L-S, Li EK. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study. Rheumatology. 2011; 50:1293-1301.
29 - Ahlstrand I, Bjӧrk M, Thyberg I, Falkmer T. Pain and difficulties performing valued life activities in women and men with rheumatoid arthritis. Clin Rheumatol. 2015; 34:1353-1362.
A nutrition guide to help your patients manage their condition optimally.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2023 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021